Phase II Study of Ramucirumab With Chemotherapy in Patients With Metastatic Gastroesophageal Junction and Gastric Cancer
Clinical trial NCT02726399 · TERMINATED
Trial details
- NCT number
- NCT02726399
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-18
- Primary completion
- 2019-02-26
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.